Effects of treatment with ACE-inhibitor at high dose or angiotensin II receptor antagonist on arterial distensibility in heart failure

被引：0
|
作者：
Glannattasio, C
Failla, M
Achilli, F
Vincenzi, A
Grappiolo, A
Capra, A
Carugo, S
Gentile, G
Grieco, N
Valagussa, F
Mancia, G
机构：
[1] Univ Milan, Med Clin, Milan, Italy
[2] Univ Milan, Div Cardiol, Milan, Italy
[3] Osped S Gerardo Monza, RCCS, Fisiol Clin 1, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [31] ACE-inhibitor Therapy at Relatively High Doses and Risk of Renal Worsening in Chronic Heart Failure
    De Vecchis, R.
    Di Biase, G.
    Ariano, C.
    Cioppa, C.
    Giasi, A.
    Ciccarelli, A.
    Pucciarelli, A.
    Cantatrione, S.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 507 - 515
  • [32] DIRECT EFFECTS OF ANGIOTENSIN-I, ANGIOTENSIN-II, AN ACE-INHIBITOR AND A SERINE PROTEINASE-INHIBITOR ON CULTURED HEART-CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS
    KUZUO, H
    HONDA, M
    TANAKA, K
    KURAMOCHI, T
    MORIOKA, S
    TAKABATAKE, T
    YAMORI, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (02) : 82 - 86
  • [33] Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker
    Sato, H
    Yaoita, H
    Maehara, K
    Maruyama, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01): : H359 - H368
  • [34] Design of the Heart failure Endpoint evaluation of AII-Antagonist Losartan (HEAAL) study in patients intolerant to ACE-inhibitor
    Konstam, Marvin A.
    Poole-Wilson, Philip A.
    Dickstein, Kenneth
    Drexler, Helmut
    Justice, Steven J.
    Komajda, Michel
    Malbecq, William
    Martinez, Felipe A.
    Neaton, James D.
    Riegger, Gunter A. J.
    Guptha, Soneil
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (09) : 899 - 906
  • [35] Lifestyle changes in congestive heart failure - Combined treatment by ACE-inhibitor/NO-donator and exercise therapy
    Kothe, K
    PERFUSION, 1996, 9 (05): : 185 - 194
  • [36] LCZ-696 Angiotensin AT1 Receptor Antagonist/Neprilysin Inhibitor Treatment of Heart Failure Treatment of Hypertension
    Chrysant, Steven G.
    DRUGS OF THE FUTURE, 2011, 36 (03) : 183 - 190
  • [37] Captopril and angiotensin II receptor antagonist therapy in a pacing model of heart failure
    Ogilvie, RI
    Zborowska-Sluis, D
    CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 (08) : 1025 - 1033
  • [38] Coronary artery surgery-induced impairment of the arterial baroreflex and protective effect of high-dose statin/ACE-inhibitor treatment
    Radaelli, A.
    Balestri, G.
    Bianchi-Janetti, M.
    Cazzaniga, M.
    DeCarlini, C.
    Paolini, G.
    Menicanti, L.
    Azzellino, A.
    Castiglioni, P.
    Ferrari, A. U.
    JOURNAL OF HYPERTENSION, 2008, 26 : S321 - S321
  • [39] High dose angiotensin II type 1 receptor antagonist (AIIRA) and angiotensin converting enzyme inhibitor (ACEI) in regression of glomerulosclerosis
    Ma, LJ
    Nakamura, S
    Nakamura, I
    Marcantoni, C
    Fogo, AB
    MODERN PATHOLOGY, 2002, 15 (01) : 278A - 278A
  • [40] High dose angiotensin II type 1 receptor antagonist (AIIRA) and angiotensin converting enzyme inhibitor (ACEI) in regression of glomerulosclerosis
    Ma, LJ
    Nakamura, S
    Nakamura, I
    Marcantoni, C
    Fogo, AB
    LABORATORY INVESTIGATION, 2002, 82 (01) : 278A - 278A
12345